Applied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership
News provided by
Share this article
Share this article
CARLSBAD, Calif. and LONGMONT, Colo., April 6, 2021 /PRNewswire/ Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced today that they have entered into a strategic commercial partnership, granting ASI worldwide rights to market KromaTiD s proprietary Pinpoint FISH™ (PPF) probes and assay services. PPF is used by researchers around the world to directly analyze unique and small genomic targets in tissues, microarrays, and dissociated cells.
KromaTiD, Inc.
KromaTiD currently provides commercial dGH™ and PPF products and services to industry, institutional and academic researchers assessing the integrity of engineered cells, as well as researchers visualizing novel genomic structural variants in oncology and undiagnosed genetic diseases.